摘要
目的探讨西咪替丁联合潘生丁治疗过敏性紫癜的临床疗效。方法将在我院2012年6月至2013年6月收治的过敏性紫癜86例患者,随机分为观察组和对照组,观察组给予西咪替丁联合潘生丁治疗,对照组给予泼尼松、维生素C、维生素D、钙剂、氯雷他定治疗。比较两组患者临床疗效及不良反应的发生情况。结果观察组总有效率93.02%,对照组有效率79.07%,两组总有效率具有差异性(P<0.05)。且观察组患者皮肤紫癜消退时间,临床症状消失时间,住院天数均明显低于对照组,两组相比具有差异性(P<0.05),西咪替丁联合潘生丁也无明显不良反应。结论西米替西联合潘生丁治疗过敏性紫癜疗效显着,且无严重不良反应,使用便利,患者依从性好,值得临床广泛推广和使用。
Objective The discussion cimetidine and dipyridamole combination to treat the allergic purpura the clinical curative effect. Methods The method the allergic purpura 86 example patients who from June 2012 to June 2013 will admit in my courtyard, will divide into the observation group and the control group stochastically, the observation group gives the cimetidine and dipyridamole combination to treat, the control group will give prednisone, vitamin C, vitamin D, the calcium medicinal preparation, the loratadine. Two groups were compared the clinical efficacy and adverse reactions. Results Finally observation group total effectiveness 93.02%, control group effectiveness 79.07%, two groups of total effectiveness have the difference （P＆lt;0.05）. Also the observation group patient skin purpura retrogression time, the clinical symptom vanishing time, in hospital number of days obviously is lower than the control group, two groups compare have the difference （P＆lt;0.05）, the cimetidine and dipyridamole combination to treat patients also not obviously not good to respond.Conclusion The conclusion cimetidine and dipyridamole combination to treat the allergic purpura curative effect to be remarkable, also no serious adverse reactions, the use convenience, the patient complies is good, is worth the clinical widespread promotion and the use.
出处
《中国医药指南》
2014年第4期9-10,共2页
Guide of China Medicine
关键词
西咪替丁
潘生丁
过敏性紫癜
临床疗效
Cimetidine
Dipyridamole
Allergic purpura
Clinical efficacy
